SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Bencich John (Last) (First) (Middle) 1522 217TH PLACE SE SUITE 100 (Street) BOTHELL WA 98021 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol ONCOGENEX PHARMACEUTICALS, INC. [ OGXI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CFO and PFO
	3. Date of Earliest Transaction (Month/Day/Year) 08/12/2014
	4. If Amendment, Date of Original Filed (Month/Day/Year) 08/12/2014	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$3.17(1)	08/12/2014(1)		A		40,000		(2)	08/12/2024(1)	Common	40,000	$0.00	40,000	D
Restricted Stock Unit (RSU)	(3)	08/12/2014(1)		A		20,000		(4)	(5)	Common	20,000	$0.00	2,000	D

Explanation of Responses:

1. This amended Form 4 is filed to correct (a) the exercise price, which was inadvertently reported as $3.30, (b) the transaction date, which was inadvertently reported as August 11, 2014 and (c) the expiration date, which was inadvertently reported as August 11, 2024.

2. This amended Form 4 is filed to correct the exercisable date. The options vest monthly over 48 months, commencing on September 12, 2014, which was inadvertently reported as September 11, 2014.

3. Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.

4. This amended Form 4 is filed to correct the exercisable date. Twenty-five percent of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 12, 2014, which was inadvertently reported as August 11, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.

5. The RSUs expire 30 days from the date they vest.

Remarks:

	Sandra Thomson as attorney-in-fact for John Bencich	08/13/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.